Ligand Pharmaceuticals Profit Margin 2006-2021 | LGND
Current and historical gross margin, operating margin and net profit margin for Ligand Pharmaceuticals (LGND) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Ligand Pharmaceuticals net profit margin as of June 30, 2021 is 19.03%.
| Ligand Pharmaceuticals Annual Profit Margins |
| Ligand Pharmaceuticals Quarterly Profit Margins |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$2.273B |
$0.186B |
|
Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.
|
